Impact Biomedical IBO
NYSE IBO
$5.46 -0.14 (-2.50%)
As of: Oct 1, 2026 · 3:57 PM EDT

Impact Biomedical (IBO) Asset Utilization Ratio (2025 - 2026)

Updated

Impact Biomedical's Asset Utilization Ratio was 0.00 in Q2 2026, down 29.0% from 0.00 a year earlier but up 11.5% from the prior quarter.

Analysis

Impact Biomedical (IBO) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

From Q2 2025 onward, Impact Biomedical has reported Asset Utilization Ratio for 4 quarters.

  • Quarterly Asset Utilization Ratio has moved between 0.00 (Q3 2025) and 0.00 (Q2 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 0.49
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 0.47
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 0.52
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 0.44
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 0.53
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 0.40
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 0.58
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 0.47
10 Impact Biomedical 598.41 Mn 601.61 Mn 2,000.00 0.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Mar 31, 2026 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
API Access

Impact Biomedical Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=IBO&period=max&api_key=YOUR_API_KEY